Comparing clinical efficacy of Symbicort versus Pulmicort in reducing asthma symptom and improving its control
Background: Recently, higher efficacy of the combination of long-acting beta2-adrenoceptor agonist and inhaled corticosteroids on controlling asthma symptoms has been hypothesized. This study aimed to examine the clinical effects of the combination of Budesonide with formoterol (Symbicort) and Budes...
Main Authors: | Mohammad Emami, Azadeh Tayebi, Mojgan Gharipour, Somayeh Farzamnia, Akbar Kargari Temyarti |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2014-01-01
|
Series: | Advanced Biomedical Research |
Subjects: | |
Online Access: | http://www.advbiores.net/article.asp?issn=2277-9175;year=2014;volume=3;issue=1;spage=86;epage=86;aulast=Emami |
Similar Items
-
Comparison of the Effect of Clinical Practice Guide of Budesonide (Pulmicort) and Standard Method in the Management of Asthma Attack
by: Elham Shahbazi-Dastjerdeh, et al.
Published: (2019-09-01) -
Effect of azithromycin, montelukast combined with pulmicort respulas therapy on the degree of inflammation and lung function in children with mycoplasma pneumonia
by: Jian-mei Zhang, et al.
Published: (2016-09-01) -
Assessment of inhalation errors, training time and patient preference for DuoResp® Spiromax® and Symbicort® Turbuhaler® in patients with asthma and COPD
by: Jordi Giner, et al.
Published: (2020-01-01) -
Once-daily use of inhaled corticosteroids: A new regimen in the treatment of persistent asthma
by: Jeffrey Leflein
Published: (2000-01-01) -
Effective control of a severe exacerbation of bronchial asthma
by: V I Makolkin, et al.
Published: (2004-08-01)